NEONC Technologies (NTHI) CCO discloses 160 directly held shares in Form 3/A
Filing Impact
Filing Sentiment
Form Type
3/A
Rhea-AI Filing Summary
NEONC TECHNOLOGIES HOLDINGS, INC. executive Yousha Neman‑Ebrahim, the Chief Clinical Officer, filed an amended initial ownership report. The Form 3/A shows direct ownership of 160 shares of common stock as of June 5, 2025. The filing updates reported holdings without indicating any specific buy or sell transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Neman-Ebrahim Yousha
Role
Chief Clinical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 160 shares (Direct)
Footnotes (1)
FAQ
What does the NEONC Technologies (NTHI) Form 3/A show?
The Form 3/A shows NEONC Technologies executive Yousha Neman‑Ebrahim’s current direct holdings of common stock. It reports ownership of 160 shares, updating his initial ownership disclosure without identifying any associated purchase or sale transaction.
Is the NEONC Technologies (NTHI) Form 3/A a buy or sell filing?
The Form 3/A is not a clear buy or sell filing. It classifies the event as a holding with an unknown transaction code, indicating updated ownership information rather than a specifically identified purchase or sale.
What role does Yousha Neman-Ebrahim have at NEONC Technologies (NTHI)?
Yousha Neman‑Ebrahim serves as Chief Clinical Officer at NEONC Technologies. His Form 3/A insider filing reports his position and discloses his direct ownership of 160 shares of the company’s common stock.
Does the NEONC Technologies (NTHI) Form 3/A involve indirect ownership?
No, the filing identifies Yousha Neman‑Ebrahim’s ownership as direct. The nature of ownership field and ownership code both indicate direct holdings, with no referenced trusts, partnerships, or other indirect ownership entities in the data provided.